Amazon, JPMorgan Chase, and Berkshire Hathaway are joining together to launch a new healthcare company. They may seem like strange bedfellows in the healthcare industry, but they think their partnership and ideas could help drive down the cost of care for their employees – about 950,000 people worldwide.

How will they do it? One option is offering telemedicine technology to providers. It’s a growing service that is already widely used in our area. So what will the future of healthcare look like – not only for the employees of these companies, but for all Americans? We talk about the impact of telemedicine and other innovative services, and how they could change the way you visit your doctor. Our guests:

  • Dr. Neil Herendeen, M.D., professor of pediatrics and pediatrician at Golisano Children's Hospital
  • Cynthia Gordon, director of telehealth services at Rochester Regional Health
  • Christopher Bell, executive director of the Monroe County Medical Society
  • Lois Irwin, president of EZaccessMD


Green Party presidential candidate Dr. Jill Stein sparked a wave of headlines about vaccines when she praised vaccines, but then said that Americans no longer trust regulatory agencies that approve vaccines. Stein said that there are "real questions" about vaccines and vaccine schedules. She has been roundly condemned by doctors, but she's not the only presidential candidate to dispute the facts on vaccines (Donald Trump has, too.).

This month, the medical community is pushing vaccine awareness, urging everyone to understand the facts and the tremendous benefits of vaccines. Our guests discuss it:


Governor Cuomo and leaders in the Senate and Assembly say that have reached an agreement on a package of bills aimed at combating heroin and opioid abuse.

Among the many measures agreed to by lawmakers: limiting opioid prescriptions for acute pain to seven days, requiring insurance companies to cover more of the cost for rehab and recovery programs, as well as enhanced treatment services

One local doctor says that's a great start, but more should be done.

In this episode of Second Opinion LIVE, we focus on headaches: from migraines, to tension headaches, to stress headaches, and more. We discuss diagnosis and new treatments with our guests:

  • Lou Papa, M.D., primary care physician at Olsan Medical Group, and professor of clinical medicine at the University of Rochester Medical Center
  • Joseph Mann, M.D., physician at Greater Rochester Neurology, and clinical assistant professor in the Department of Neurology at the University of Rochester Medical Center

Check out these three recent headlines:

CBS News: Zika virus likely to spread to southern U.S.
NPR: Big Zika virus outbreak unlikely in the U.S.
Washington Post: Why the United States is so vulnerable to the alarming spread of Zika

Why the disparity? We welcome an infectious disease specialist from Brazil who is working with URMC physicians and scientists on disease studies. He has witnessed the Zika outbreak in Brazil and has treated pregnant women with the virus. Our guests:

  • Dr. Esper Kallas, infectious diseases specialist and professor of medicine at the University of Sao Paulo, Brazil
  • Dr. John Treanor, chief of infectious diseases at UR Medicine's Strong Memorial Hospital
  • Dr. Eva Pressman, chair of the Department of Obstetrics and Gynecology at UR Medicine's Strong Memorial Hospital

In this episode of Second Opinion LIVE, we take an in-depth look at the pharmaceuticals and nutraceuticals (supplements) that we are putting in our body. We discuss how we take them, if all are created equally, and if they are really making us healthier. Our guests:

  • Roger Oskvig, M.D., professor of clinical medicine and geriatrician at the University of Rochester Medical Center
  • Lisa Kuras, PharmD, clinical staff pharmacist at Highland Hospital

Texas recently brought 100 top-level researchers to the state to search for cancer treatments. How did Texas poach talent from other places? A new state priority on research funding. And now an association of New York medical schools is asking our state to do the same.

Is this how we cure certain cancers, or triumph over diseases? It's possible: the schools argue that it's also how we create jobs and prevent other states from stealing our talented men and women. So how much should taxpayers contribute, and how does the process work? Our guests:

In this episode of Second Opinion LIVE!, we talk about health resolutions for the new year. Physicians answer your questions about weight loss, exercise, smoking cessation, and more. Our guests:

We're getting up-to-speed on stem cell research. The debate was raging a decade ago: embryonic vs. adult stem cells. Many local scientists pushed for more opportunity to gain access to embryonic stem cells, given the potential to attack disease. How is research progressing? What's next? Mark Noble, professor of genetics, neurology, and anatomy at URMC will deliver a presentation later this month at the Rochester Academy of Medicine titled, "My Child Does Not Have Time for Your Ethics!". He joins us in studio along with Richard Dees, ethicist at the University of Rochester.